Eldecalcitol for sarcopenia prevention in adults with prediabetes - Authors' reply

Lancet Healthy Longev. 2024 Jun;5(6):e390-e391. doi: 10.1016/S2666-7568(24)00090-4.

Authors

Tetsuya Kawahara¹, Gen Suzuki², Shoichi Mizuno³

Affiliations

¹ Department of Endocrinology and Diabetes, Shin Komonji Hospital, Kitakyushu 800-0057, Japan. Electronic address: [email protected].
² Department of Internal Medicine, International University Health and Welfare Clinic, Ohtawara, Japan.
³ Division of Cancer Immunotherapy, National Cancer Center EPOC, Kashiwa, Japan.

PMID: 38824955
DOI: 10.1016/S2666-7568(24)00090-4

No abstract available

Publication types

Letter

MeSH terms

Adult
Humans
Prediabetic State* / drug therapy
Sarcopenia* / prevention & control
Vitamin D* / administration & dosage
Vitamin D* / analogs & derivatives
Vitamin D* / therapeutic use

Substances

Vitamin D
eldecalcitol